Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) Equity Average (2016 - 2025)

Historic Equity Average for Ekso Bionics Holdings (EKSO) over the last 13 years, with Q3 2025 value amounting to $10.3 million.

  • Ekso Bionics Holdings' Equity Average fell 2346.91% to $10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.3 million, marking a year-over-year decrease of 2346.91%. This contributed to the annual value of $12.7 million for FY2024, which is 3347.09% down from last year.
  • Per Ekso Bionics Holdings' latest filing, its Equity Average stood at $10.3 million for Q3 2025, which was down 2346.91% from $11.8 million recorded in Q2 2025.
  • Ekso Bionics Holdings' 5-year Equity Average high stood at $40.5 million for Q2 2021, and its period low was $10.3 million during Q3 2025.
  • In the last 5 years, Ekso Bionics Holdings' Equity Average had a median value of $19.5 million in 2023 and averaged $22.5 million.
  • As far as peak fluctuations go, Ekso Bionics Holdings' Equity Average surged by 145905.77% in 2021, and later crashed by 4845.53% in 2023.
  • Quarter analysis of 5 years shows Ekso Bionics Holdings' Equity Average stood at $38.1 million in 2021, then decreased by 29.14% to $27.0 million in 2022, then tumbled by 48.46% to $13.9 million in 2023, then fell by 1.03% to $13.8 million in 2024, then decreased by 25.27% to $10.3 million in 2025.
  • Its last three reported values are $10.3 million in Q3 2025, $11.8 million for Q2 2025, and $12.7 million during Q1 2025.